Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV001143023 | SCV001303520 | uncertain significance | Alport syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003490085 | SCV004241233 | likely benign | not specified | 2023-12-18 | criteria provided, single submitter | clinical testing | Variant summary: COL4A3 c.-10C>T is located in the untranslated mRNA region upstream of the initiation codon. The variant allele was found at a frequency of 0.00028 in 1530590 control chromosomes in the gnomAD database, including 4 homozygotes. c.-10C>T has been reported in the literature in individuals affected with Alport Syndrome, however the authors indicate it is likely a co-occurring polymorphism, suggesting a benign role (e.g., Vega_2003). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 14582039). One submitter has cited clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely benign. |
Immunogenetics and Transplant Biology Service, |
RCV003991040 | SCV004037597 | likely benign | Autosomal dominant Alport syndrome | 2023-07-03 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003938498 | SCV004759610 | likely benign | COL4A3-related disorder | 2020-03-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |